The IMP3 gene, also called the IGF2BP3 gene, helps cells manage genetic messages that guide growth, movement, and early development. In medicine, this gene is important because it helps regulate when certain proteins are made. If it is too active or switched on in the wrong tissues, cells may grow and spread in a less controlled way, which is why it is linked to several cancers. IMP3 is more familiar in pathology labs than in popular culture, where it is often used as a lab marker that can help doctors classify some tumors.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the information needed to make proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. If you want to go further into this topic, you can find more in the LearnHub.
Overview
IMP3Gene function
What if the gene works
The IMP3 name usually refers to the IGF2BP3 gene. This gene helps cells control certain RNA messages, which guide protein production. It is most active during early development and supports cell growth and movement.
Risk
What if the gene does not work
Changes in the IMP3 gene can range from milder to more severe and may reduce how well cells handle and transport certain RNA messages. This can disrupt when growth-related proteins are made and how strongly those messages are protected.
Treatment
What does that mean for your treatment
At present, no IMP3-specific treatment, management plan, or drug-selection approach is established in clinical guidelines for pathogenic or loss-of-function variants in the IMP3 gene.
Gene function
What if the gene works
Your cells use the IMP3 gene during one of their busiest everyday jobs: building ribosomes, the structures that make proteins. Its protein works mainly in the nucleolus, a small area inside the cell where ribosome parts are prepared. When this process runs smoothly, cells can make mature ribosome components and support normal protein production.
The IMP3 gene helps assemble the small part of ribosomes, the cell structures that make proteins. It supports the orderly early steps that turn raw cell material into a working ribosome piece.
Its protein helps trim and shape ribosomal RNA, the RNA used to build ribosomes. This step produces mature 18S ribosomal RNA, one of the finished RNA parts needed for the small ribosome subunit.
In practical terms, IMP3 gene function supports steady protein production by helping cells prepare ribosomes correctly. This basic job helps many tissues keep up with everyday growth, repair, and maintenance.
What is a variant?
A genetic variant is a small alteration in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental factors. Many variants have no visible effect and are simply part of natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IMP3 gene can change the shape, stability, or amount of IMP3 protein, which may weaken its role in building ribosomes, the cell structures that make proteins. What happens if the IMP3 gene does not work often depends on the variant: milder changes may leave some activity, while more disruptive variants can sharply reduce protein function or lead to a shortened protein. These changes can interfere with early ribosome assembly inside cells.
How variants are linked to conditions
Current evidence does not show a broadly confirmed pattern of IMP3 gene variants linked to conditions in routine clinical genetics. If you have a confirmed change in the IMP3 gene, your doctor or genetic counselor can explain what it may mean for you and your family.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the IMP3 gene. If IMP3 shows up in test results, its meaning depends a lot on the exact change and the health condition being evaluated, so personal risk is best reviewed with a doctor or genetic counselor.
Inheritance of IMP3 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the IMP3 gene, so the inheritance of IMP3 gene variants is still described cautiously. The IMP3 gene is located on chromosome 6, which is an autosome, so you inherit one copy from each parent. In general, either parent can pass on an IMP3 variant to a child.
What does my IMP3 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the IMP3 gene. If you have an IMP3 result and want to understand what it could mean for your family members, a doctor or genetic counselor can explain it in the context of your exact result and family history.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the IMP3 gene usually uses a blood sample or cheek swab. A lab reads the gene’s DNA sequence and compares it with the usual sequence, so testing for variants in the IMP3 gene can show whether a change is present. Results may report a variant, no variant found, or a variant of uncertain significance.
When should I consider getting a genetic test?
There is not yet a broadly established reason to get genetic testing focused only on the IMP3 gene. Testing decisions are usually made with a doctor or genetic counselor, based on your symptoms, family history, and whether a broader test would be more useful.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment and have different results because their bodies may absorb, break down, or respond to the drug in different ways. These differences are common and can influence how well a medicine works or how likely someone is to notice side effects. Genetic information is one part of the picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies patterns linking genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the IMP3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about side effects, treatment response, or other health concerns are best discussed with your doctor. IMP3 has been studied in some cancers as a marker linked with how tumors behave and sometimes how they respond to treatment, but it is not a routine guide for prescribing.
History
The IMP3 gene entered medical research through studies of proteins active during early development and later quiet in most adult tissues. In recent decades, awareness of this gene’s role has grown as pathologists began using IMP3 as a tissue marker in cancer diagnosis. Early work linked it to embryo and placenta development, which is why it was often described as an “oncofetal” marker when found again in certain tumors. From these first observations, research expanded steadily, and IMP3 became part of routine discussions in surgical pathology and cancer studies. Its history is mainly tied to how doctors learned to distinguish different tumors more accurately under the microscope.